Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Trovagene, Inc. patents

List of Trovagene, Inc. patents

List of Asante Solutions patents

List of Cyph patents

List of Engineering Acoustics Incorporated patents

List of funding rounds for Zededa

CEOs of association football companies

Patents where

Current Assignee

Name

is

‌

Trovagene, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7803929 Kits for diagnosis and monitoring of pathogenic infection by analysis of cell-free pathogenic nucleic acids in urine	Patent 7803929 was granted and assigned to Trovagene, Inc. on September, 2010 by the United States Patent and Trademark Office.		‌ Trovagene, Inc.		United States Patent and Trademark Office	7803929	September 28, 2010
	‌ US Patent 7973154 Kits for diagnosis and monitoring of viral infection by analysis of viral transrenal nucleic acids in urine	Patent 7973154 was granted and assigned to Trovagene, Inc. on July, 2011 by the United States Patent and Trademark Office.		‌ Trovagene, Inc.		United States Patent and Trademark Office	7973154	July 5, 2011
	‌ US Patent 9725755 Synthesis and enrichment of nucleic acid sequences	Patent 9725755 was granted and assigned to Trovagene, Inc. on August, 2017 by the United States Patent and Trademark Office.	‌ Trovagene, Inc.	‌ Trovagene, Inc.		United States Patent and Trademark Office	9725755	August 8, 2017
	‌ US Patent 7914982 Methods for detecting pathogen specific nucleic acids in urine	Patent 7914982 was granted and assigned to Trovagene, Inc. on March, 2011 by the United States Patent and Trademark Office.		‌ Trovagene, Inc.		United States Patent and Trademark Office	7914982	March 29, 2011
	‌ US Patent 8486626 Methods of detecting cell-free miRNA in urine and blood	Patent 8486626 was granted and assigned to Trovagene, Inc. on July, 2013 by the United States Patent and Trademark Office.		‌ Trovagene, Inc.		United States Patent and Trademark Office	8486626	July 16, 2013
	‌ US Patent 9816148 Amplification and sequencing of transrenal nucleic acids	Patent 9816148 was granted and assigned to Trovagene, Inc. on November, 2017 by the United States Patent and Trademark Office.	‌ Trovagene, Inc.	‌ Trovagene, Inc.		United States Patent and Trademark Office	9816148	November 14, 2017
	‌ US Patent 9909118 Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media	Patent 9909118 was granted and assigned to Trovagene, Inc. on March, 2018 by the United States Patent and Trademark Office.	‌ Trovagene, Inc.	‌ Trovagene, Inc.		United States Patent and Trademark Office	9909118	March 6, 2018
	‌ US Patent 9453265 Method for detection of high risk human papillomavirus	Patent 9453265 was granted and assigned to Trovagene, Inc. on September, 2016 by the United States Patent and Trademark Office.	‌ Trovagene, Inc.	‌ Trovagene, Inc.		United States Patent and Trademark Office	9453265	September 27, 2016
	‌ US Patent 8383335 Method for diagnosis and monitoring of viral infection by analysis of viral transrenal nucleic acids in urine	Patent 8383335 was granted and assigned to Trovagene, Inc. on February, 2013 by the United States Patent and Trademark Office.		‌ Trovagene, Inc.		United States Patent and Trademark Office	8383335	February 26, 2013
	‌ US Patent 9725767 Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof	Patent 9725767 was granted and assigned to Trovagene, Inc. on August, 2017 by the United States Patent and Trademark Office.		‌ Trovagene, Inc.		United States Patent and Trademark Office	9725767	August 8, 2017
	‌ US Patent 8642261 Genetic marker for detection of human papillomavirus	Patent 8642261 was granted and assigned to Trovagene, Inc. on February, 2014 by the United States Patent and Trademark Office.		‌ Trovagene, Inc.		United States Patent and Trademark Office	8642261	February 4, 2014
	‌ US Patent 9222137 Method for monitoring minimal residual hairy cell leukemia	Patent 9222137 was granted and assigned to Trovagene, Inc. on December, 2015 by the United States Patent and Trademark Office.		‌ Trovagene, Inc.		United States Patent and Trademark Office	9222137	December 29, 2015
	‌ US Patent 9163229 Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media	Patent 9163229 was granted and assigned to Trovagene, Inc. on October, 2015 by the United States Patent and Trademark Office.		‌ Trovagene, Inc.		United States Patent and Trademark Office	9163229	October 20, 2015

13 results

0 selected

13 results

0 selected